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Abstract
Background: Three to five percent of patients with acute myocardial infarction (AMI) have normal coronary arteries
on invasive coronary angiography (ICA). The aim of this study was to assess the presence and characteristics
of atherosclerotic plaques on computed tomography coronary angiography (CTCA) and describe the clinical
characteristics of this group of patients.
Methods: This was a multicentre, prospective, descriptive study on CTCA evaluation in thirty patients fulfilling
criteria for AMI and without visible coronary plaques on ICA. CTCA evaluation was performed head to head
in consensus by two experienced observers blinded to baseline patient characteristics and ICA results. Analysis
of plaque characteristics and plaque effect on the arterial lumen was performed. Coronary segments were
visually scored for the presence of plaque. Seventeen segments were differentiated, according to a modified
American Heart Association classification. Echocardiography performed according to routine during the initial
hospitalisation was retrieved for analysis of wall motion abnormalities and left ventricular systolic function in
most patients.
Results: Twenty-five patients presented with non ST-elevation myocardial infarction (NSTEMI) and five with
ST-elevation myocardial infarction (STEMI). Mean age was 60.2 years and 23/30 were women. The prevalence
of risk factors of coronary artery disease (CAD) was low. In total, 452 coronary segments were analysed. Eighty
percent (24/30) had completely normal coronary arteries and twenty percent (6/30) had coronary atherosclerosis on
CTCA. In patients with atherosclerotic plaques, the median number of segments with plaque per patient was one.
Echocardiography was normal in 4/22 patients based on normal global longitudinal strain (GLS) and normal wall
motion score index (WMSI); 4/22 patients had normal GLS with pathological WMSI; 3/22 patients had pathological GLS
and normal WMSI; 11/22 patients had pathological GLS and WMSI and among them we could identify 5 patients with
a Takotsubo pattern on echo.
Conclusions: Despite a diagnosis of AMI, 80 % of patients with normal ICA showed no coronary plaques on CTCA.
The remaining 20 % had only minimal non-obstructive atherosclerosis. Patients fulfilling clinical criteria for AMI but
with completely normal ICA need further evaluation, suggestively with magnetic resonance imaging (MRI).
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Background
Acute myocardial infarction usually results from throm-
botic occlusion of a coronary artery due to a ruptured
atherosclerotic plaque. However, about 3 to 5 % of pa-
tients [1, 2] fulfil criteria for myocardial infarction but
have angiographically normal coronary arteries (MINCA).
The pathogenetic mechanisms involved in the develop-
ment of AMI in the patient with no visible coronary ath-
erosclerosis on the ICA are unclear.
Alterations in the endothelium and/or components in
the blood promoting endothelial dysfunction and the
formation of thrombotic occlusion have been suggested
[3, 4]. According to Glagov [5] atherosclerotic plaques
can cause outward remodelling of the coronary vessel
without significant obstruction and therefore can be in-
visible on ICA. However, such plaques are prone to
rupture and manifest as an acute myocardial infarction
[6]. Other proposed mechanisms are coronary dissec-
tion, embolism and vasospasm [7–9] as well as spontan-
eous thrombus resolution [10].
Although ICA has been the gold standard for the
diagnosis of coronary artery disease, lumenography
provides merely an image of the internal arterial lumen
and lacks the capability to adequately depict the vessel
wall with its developing atherosclerotic plaque. Previ-
ous studies analysing serial angiograms from patients
presenting with acute coronary syndrome (ACS) have
suggested that in nearly two thirds of the culprit le-
sions, the coronary angiogram obtained a few months
before the acute event demonstrated a non-significant
stenosis [11].
Imaging of the coronary vessels with computed tom-
ography has been proposed as a method for qualitative
imaging of vessel wall changes [12]. CTCA has a high
negative predictive value, but tends to overestimate the
degree of stenosis [13–15]. Previous studies have shown
that CTCA is comparable to intravascular ultrasound
(IVUS) for classifying plaques [16–18].
This group of patients with acute myocardial infarction
and angiographically normal coronary arteries is broadly
recognised and described in previous studies [19, 20].
They are often described as being younger than the “clas-
sical” myocardial infarction patients and have lower bur-
den of cardiovascular risk factors but the pathogenesis of
this kind of presentation of myocardial infarction is still
debatable.
We hypothesised that atherosclerotic plaques will be
detected by CTCA in patients with acute myocardial in-
farction and completely normal coronary arteries on
ICA. This is an extension and refinement of prior work
in this area, which has tended to include significant
numbers of patients with non-obstructive atheroma on




This was a multicentre, prospective, descriptive study
carried out in 3 hospitals in southeast Sweden, Linköping,
Kalmar and Jönköping, from November 2008 to January
2011. Patients were included at the local hospital where
they presented with myocardial infarction and underwent
an ICA which showed completely normal coronary arter-
ies. After inclusion they were referred to the University
Hospital in Linköping for the CTCA part of the study.
Inclusion criteria for the study were: myocardial infarction
according to the ESC guidelines of 2007 [including signifi-
cant rise and/or fall of cardiac troponin with at least one
value above the 99th percentile of upper limit of normal
(ULN), clinical features consistent with ischemia (various
combinations of chest, upper extremity, mandibular or
epigastric discomfort or an ischaemic equivalent such as
dyspnoea or fatigue) and/or ischemic ECG changes] with
no visible atherosclerosis on ICA as assessed by two
independent experienced operators [21]. Patients with
a reasonable alternative explanation for their symp-
toms and elevated troponin were not included in the
study after adjudication. The exclusion criteria were:
inability to perform CTCA (contraindications to beta-
blockers or nitroglycerine, hypersensitivity to contrast
medium, pregnancy and permanent atrial fibrillation),
renal dysfunction (eGFR <60 ml/min) or risk factors
for contrast induced acute kidney injury (treatment with
metformin, high dose diuretics), recent major trauma, sur-
gery or percutaneous coronary intervention (PCI).
Troponin analysis
Three different troponin assay methods were used dur-
ing the course of the study according to local routines.
Troponin I (Stratus CS, Siemens, ULN: 0,07 μg/L),
Troponin T (AQT 90, Radiometer, ULN: 0,01 μg/L) and
hs-Troponin T (Elecsys/Cobas, Roche Diagnostics, ULN:
15 ng/L).
Computed tomography coronary angiography, image
acquisition
CTCA was performed at the University Hospital Linköping
using a 64-slice or a 128-slice dual source CT scanner
(Somatom Definition or Somatom Definition Flash,
Siemens Healthcare, Forchheim, Germany). During CTCA
acquisition non-ionic contrast medium was administered,
60–50 ml, 370 mg I/ml, 5 ml/sec, Jopromid. Intravenous
beta-blockers were administered for optimal image qual-
ity. Additionally, nitroglycerine was administered to all pa-
tients before the scan. Strategies to reduce radiation dose,
including electrocardiogram gated tube current modula-
tion, prospective triggering and reduction of tube voltage
were used whenever feasible.
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The following scan parameters were used for 64 slice
CT scanner: 64 × 2 slices with 0.6 mm collimation, gan-
try rotation time of 330 ms, tube voltage 100 or 120 mV,
and effective tube current of 320 to 412 mAs. The fol-
lowing settings were used for the 128-slice CT scanner:
128 × 2 slices with 0.6 mm collimation, gantry rotation
time of 280 ms, tube voltage 100 or 120 mV, and effect-
ive tube current of 320 to 370 mAs.
Computed tomography coronary angiography, image
analysis
CTCA datasets were evaluated on a remote workstation
with dedicated software (QAngio CT, Medis Medical
Imaging Systems, Leiden, the Netherlands) [22]. Evalu-
ation was performed side by side in consensus by two
experienced observers blinded to baseline patient charac-
teristics and ICA results. Analysis of plaque characteristics
and plaque effect on the arterial lumen was performed at
a predefined window and level setting (window 900, level
250 Hounsfield units) [23]. If considered necessary, display
settings were manipulated in order to achieve optimal
discrimination of vessel lumen and plaque components
and minimise blooming artefacts of calcified plaques. Cor-
onary segments were visually scored for the presence of
plaque. Seventeen segments were differentiated, according
to a modified American Heart Association classification
[24]. Tissue structures >1 mm2 either within the coronary
artery lumen or adjacent to the coronary artery lumen
which could be discriminated from surrounding pericar-
dial tissue, epicardial fat, or the vessel lumen, were defined
as coronary plaques. The degree of stenosis of atheroscler-
otic lesions was quantified by visual estimation. Plaques
with ≥50 % luminal narrowing were classified as obstruct-
ive. Plaques were classified according to their composition
into three types: 1. Non-calcified plaque (plaques with low
density compared to contrast-enhanced lumen), 2. calcified
plaque (plaques with high density structures compared to
the contrast-enhanced lumen), or 3. mixed plaque
(non-calcified and calcified elements in single plaque).
The accuracy for detecting atherosclerosis using CTCA
is very high [25].
Echocardiography
An echocardiography subgroup consisting of 22 patients,
where images could be retrieved for analysis of wall motion
abnormalities and left ventricular systolic function and five
additional patients where only the written echo report was
available, was studied. Three patients were not examined
by echocardiography or the data is missing. Echocardiog-
raphy was performed with GE Vivid E7, E9, Vivid-I, Sie-
mens Sequoia or Philips IE33. All recordings were
imported into Siemens US Syngo Workplace v. 3.5 and
analysed with the VVI software. For image analysis, the
endocardial border of the left ventricle was traced from the
mitral annulus to the apex and back to the contralateral an-
nulus. If tracking was satisfactory, longitudinal strain data
was stored in Excel. Three tracings per view were acquired
and the mean global value calculated. Values higher than
−17 were regarded as pathological. In addition, a wall mo-
tion score index was calculated based on the scoring of
each segment in terms of 1 = normal, 2 = hypokinetic, 3 =
akinetic and 4 = dyskinetic wall motion. The index was 1.0
if all segments were deemed normal.
Statistical analysis
Continuous variables are presented as mean ± SD when
normally distributed and as medians with interquartile
range (IQR) when skewed. Categorical variables are pre-
sented as numbers and percentages. Statistical analyses
were performed using SPSS version 20 (Chicago, IL).
Ethics
The study complies with the Declaration of Helsinki.
Approval was obtained from the Regional Ethical Review




Thirty patients were enrolled in the study. Patient char-
acteristics are displayed in Table 1.
Table 1 Patient characteristics
No. of patients 30
Mean age, years 60.2 ± 8.9
Females 23 (77 %)
Risk factors
Previous or present smoker 17 (57 %)
Diabetes mellitus 0 (0 %)
Hypertension 7 (23 %)
Hyperlipidaemia 5 (17 %)
Previous myocardial infarction 3 (10 %)
Previous stroke 0 (0 %)
Clinical presentation
NSTEMI 28 (93 %)
STEMI 2 (7 %)
Laboratory results
Creatinine on admission (µmol/L) 75.0 (61.0–81.3)
Cholesterol (mmol/L) 5.2 (4.8–6.1)
HDL-cholesterol (mmol/L) 1.6 (1.2–2.1)
LDL-cholesterol (mmol/L) 3.1 (2.5–3.9)
The data are mean ± SD, median, IQR, or numbers (%)
IQR interquartile range, HDL high density lipoprotein, LDL low density
lipoprotein, NSTEMI non ST-elevation myocardial infarction, SD standard
deviation, STEMI ST-elevation myocardial infarction
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Twenty-five patients presented with NSTEMI and five
with STEMI. Mean age of the study population was 60.2
years (51.3–69.1) and 23/30 (77 %) were female. 17/30
(57 %) were previous or active smokers, 7/30 (23 %) had
hypertension, 5/30 (17 %) had hypercholesterolemia and
none had diabetes. There were 3/30 (10 %) patients who
were previously diagnosed with myocardial infarction.
Troponin levels of all patients were significantly elevated
with a median maximum troponin level 23,6 × ULN.
None of the patients had atrial fibrillation/flutter or other
types of supraventricular or ventricular tachycardia at
presentation or during hospitalisation, neither was there a
prior history of arrhythmia. Only 1 patient died during a
mean follow-up of 5.5 years.
Computed tomography coronary angiography
The CTCA was performed within 3 days after ICA. A
total number of 452 segments were analysed. All coronary
artery segments were of diagnostic image quality. A total
of 24 patients had normal coronary arteries, and 6 patients
had coronary atherosclerosis. In the case of atheroscler-
osis, the median number of segments with plaque per
patient was one. In total, 9 segments with non-obstructive
plaque were identified in these 6 patients. Four patients
showed plaque in just one segment, one patient showed
plaque in 2 segments and one patient had plaque in three
coronary segments. Two plaques were classified as non-
calcified, five plaques as calcified and two plaques were
mixed.
Echocardiography subgroup
In 4/22 patients echocardiography was normal including
normal global longitudinal strain (GLS) and normal wall
motion score index (WMSI). 4/22 patients had normal
GLS with pathological WMSI. 3/22 patients had patho-
logical GLS and normal WMSI. 11/22 patients had patho-
logical GLS and WMSI and among them we could
identify 5 patients with Takotsubo pattern on echo (i.e.
extensive area of mostly apical hypokinesia but not limited
to the coronary artery perfusion territories). Mean ejection
fraction (EF) was 55.9 ± 8.8 %, mean GLS-14.9 ± 3.2 % and
WMSI 1.2 ± 0.24.
Among the 5 patients with only the echocardiography
report available, 4 patients had normal systolic function
with no wall motion abnormalities (WMA) and 1 patient
had apical hypokinesia with normal systolic function.
Possible diagnosis
Based on the results of CTCA and echocardiography, the
22 patients with echocardiographic images available were
grouped according to different possible diagnoses (Table 2).
The 6 patients who had coronary plaque on CTCA
(Nr 1-6 in Table 2) were regarded as having a possible
myocardial infarction due to plaque rupture. Mean EF in
this group was 55.3 ± 9.8 %, mean GLS −16.0 ± 3.1 and
mean WMSI 1.2 ± 0.3. Median maximum troponin level
was 82 (12–101) × ULN.
Five patients without any plaques on CTCA had pos-
sible Takotsubo cardiomyopathy with the typical spatial
distribution on echocardiography (Nr 7-11 in Table 2).
The motion pattern of the left ventricular wall character-
istic of Takotsubo cardiomyopathy is shown in the echo-
cardiography of patient Nr 9 (see Additional files 1 and
2). In this group the mean EF was 54.0 ± 12.7 %, mean
GLS −11.9 ± 3.0 and mean WMSI 1.5 ± 0,2. Median
maximum troponin level was 119 (52–176) × ULN.
Six patients with no plaques on CTCA but with WMA
on echocardiography (Nr 12-17 in Table 2) could have
had a myocardial infarction due to a mechanism not
involving plaque rupture (i.e. coronary dissection, em-
bolism and vasospasm) or may not have had a myocar-
dial infarction at all but myocarditis. An additional
movie file shows the echocardiography of patient Nr 14
with suspected myocarditis (see Additional files 3 and
4). This group had a mean EF 58.0 ± 6.6 %, mean GLS
−15.2 ± 2.5 and mean WMSI 1.2 ± 0.1. Median max-
imum troponin level was 19 (12–23) × ULN.
Five patients showed no plaque on CTCA and no
WMA either (Nr 18-22 in Table 2). In this group the
diagnosis is more uncertain. Some possible explanations
could be a mild myocarditis with maintained wall mo-
tion, pulmonary embolism or undiagnosed paroxysmal
tachycardia. In this group the mean EF was 54.2 ± 7.6 %
and mean GLS −16.1 ± 2.8. WMSI was 1 in all 5 patients.
Median maximum troponin level was 17 (4–21) × ULN.
Pharmacological treatment
At the time of discharge from the hospital the majority
of patients, 28/30 (93 %) had been treated with acetyl
salicylic acid, 28/30 (93 %) with statin, 25/30 (83 %)
with beta-blocker and 22/30 (73 %) with clopidogrel.
Half of the patients were discharged with angiotensin
converting enzyme inhibitor (ACEI) or angiotensin re-
ceptor blocker (ARB). At the time of admission only a
small percentage of patients, 9/30 (30 %) had any medi-
cation. In particular, 4 patients (13 %) were treated with
acetylsalicylic acid, 5 patients (17 %) with beta blocker,
4 patients (13 %) with statin, 2 patients (7 %) with ACEI
or ARB and 1 patient (3 %) with clopidogrel, calcium
antagonist or diuretics.
Discussion
Contrary to our hypothesis and previous study findings
[19], we found that the majority of our patients (80 %),
who were diagnosed with AMI and lacked visible athero-
sclerosis on a routine invasive coronary angiography, had
totally normal coronary arteries on CTCA as well. The
remaining 20 % had only minimal, one-segment, non-
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obstructive atherosclerosis. The absence of atherosclerosis
in the large majority of patients and the limited extent of
atherosclerosis found in the remaining minority might
suggest that other diagnoses than acute myocardial infarc-
tion are likely for most patients in this population. Echo-
cardiography was available in a subgroup of patients and
is known to provide sensitive and objective parameters for
left ventricle systolic function such as GLS and WMSI
that may help in arriving at a proper diagnosis. The
addition of echocardiography to the CTCA findings en-
abled a probable diagnosis in the majority of the patients
(17/22 in the echocardiography subgroup). For example,
patients with atherosclerosis on CTCA and WMA on
echocardiography could likely have had an acute myocar-
dial infarction (based on plaque rupture) in the absence of
other alternative explanations for their symptoms and ele-
vated troponin. Echocardiography can additionally identify
cases of Takotsubo cardiomyopathy (5/22 in the echocardi-
ography subgroup). Abnormal echocardiography without
any coronary atherosclerosis on CTCA indicates either
myocarditis or myocardial infarction with a mechanism
different from plaque rupture. In case of normal findings
on CTCA and echocardiography, other factors such as
mild myocarditis, arrhythmia, pulmonary embolism or
renal failure (exclusion criterion in this study) seems more
likely to explain the elevated troponins. Most patients in
Table 2 Clinical and imaging characteristics – possible diagnosis
Nr Age Gender ECG Troponin x ULN Plaque (composition) Possible Takotsubo WMSI GLS EF (%)
1 43 Male Normal 101 Yes (mixed) No 1.06 −17.8 49
2 71 Female ST-T abnormalities 155 Yes (calcified) No 1 −18.9 58
3 59 Male new LBBB 87 Yes (non-calcified) No 1 −13.4 72
4 57 Male Normal 8 Yes (non-calcified) No 1.18 −19.5 59
5 73 Female ST-T abnormalities 12 Yes (calcified) No 1.71 −13.3 48
6 69 Female ST-elevation 77 Yes (calcified) No 1.12 −12.8 46
7 69 Female ST-elevation 36 No Yes 1.47 −14.6 61
8 60 Female new RBBB 119 No Yes 1.53 −13.4 54
9 53 Female Normal 140 No Yes 1.18 −14.2 53
10 66 Female Old LBBB 68 No Yes 1.76 −8.7 34
11 64 Female ST-elevation 211 No Yes 1.53 −8.6 68
12 66 Female ST-T abnormalities 23 No No 1.18 −13.8 46
13 44 Female ST-T abnormalities 12 No No 1.18 −14.1 63
14 54 Female ST-T abnormalities 9 No No 1.06 −18.7 64
15 55 Female ST-elevation 21 No No 1.29 −13.5 57
16 63 Male Normal 16 No No 1.12 −13.0 57
17 57 Female ST-elevation 286 No No 1.12 −17.9 61
18 60 Female Normal 17 No No 1 −17.7 66
19 48 Male Normal 6 No No 1 −17.4 53
20 63 Female Normal 2 No No 1 −18.4 50
21 64 Female Normal 24 No No 1 −11.5 56
22 58 Female Normal 17 No No 1 −15.5 46
Nr Age Gender ECG Troponin x ULN Plaque (composition) Echo report
23 55 Female Normal 58 No No WMA, normal systolic function
24 64 Female ST-T abnormalities 38 No No WMA, normal systolic function
25 58 Male Normal 8 No No WMA, normal systolic function
26 63 Female Old myocardiall infarction 11 No Apical hypokinesis, normal systolic function
27 35 Male Normal 67 No No WMA, normal systolic function
28 71 Female Old myocardial infarction 11 No Not available
29 68 Female ST-T abnormalities 5 No Not available
30 64 Female Normal 39 No Not available
Echocardiography studies could not be retrieved for patients Nr 23-30. Written echo-report is available for patients Nr 23-27
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the study were prescribed acetylsalicylic acid and a great
proportion of them were sent home with dual antiplatelet
therapy, beta-blocker and statin, thus being treated as
“classical” AMI patients. We do know however, that pa-
tients with AMI and insignificant coronary atherosclerosis
have a lower incidence of adverse outcomes compared with
patients with significant coronary artery disease [26]. Since
these patients have a lower burden of risk factors, such
extensive medication may seem inappropriate and poten-
tially harmful.
When comparing with previous studies we found that
the mean age of our study population, which was 60.2 years
is in accordance with previously observed age for most first
time AMI [27, 28]. The prevalence of risk factors was lower
from what was observed in large epidemiological studies
where the prevalence of diabetes, hypertension and hyper-
lipidemia was 18.5 %, 39.0 % and 90 % respectively [29]. In
our small study the prevalence was 0 % for diabetes, 23 %
for hypertension and 17 % for hyperlipidemia supporting a
non-atherosclerotic etiology or a non AMI diagnosis in the
majority. Most patients were women, 77 %, (23/30), which
is in accordance with previous analyses where female gen-
der was the strongest predictor of insignificant CAD in
patients with NSTEMI [26]. The most frequent cause of
AMI in similar female populations with non-obstructive
CAD was previously found to be plaque rupture and ulcer-
ation [30]. The small percentage of patients having non-
obstructive plaques on CTCA in our study compared with
other studies [19, 20] is probably due to the more stringent
criteria for inclusion requiring a totally normal angiogram
whereas in previous studies patients with non-obstructive
atherosclerosis up to 30–50 % on ICA were included. This
study shows that if a normal coronary angiogram is found
after a diagnosis of AMI, the CTCA will most probably also
be normal or show only minimal atherosclerosis.
The theory of rupture of a non-obstructive plaque as an
explanation for this population’s clinical presentation does
not seem justified in 80 % of our population which had no
signs of atherosclerosis at all (either on ICA or on CTCA).
This fact leaves mechanisms like vasospasm, dissection,
embolism and impaired coagulation and fibrinolysis more
likely to be part of the pathogenesis of AMI. Non AMI
diagnoses such as myocarditis, Takotsubo cardiomyop-
athy, pulmonary embolism and arrhythmias are also pos-
sible causes for this type of presentation. It is reasonable
to consider using an intravascular imaging method [optical
coherence tomography (OCT) or IVUS] to provide infor-
mation about some mechanisms of coronary damage (i.e.
plaque rupture, dissection or ulceration) in the case of
AMI without coronary atherosclerosis but with wall
motion abnormalities suggesting myocardial injury in
a coronary artery territory or angiographic evidence
of plaque rupture or impaired flow. Even if these pa-
tients fulfilled current diagnostic criteria for myocardial
infarction, alternative explanations for chest pain and
positive biomarkers may have been overlooked. In this
clinical situation with leaking biomarkers and a normal
coronary angiogram, cardiac MRI is of great importance
for a definite diagnosis as it can differentiate between
AMI, myocarditis and Takotsubo cardiomyopathy. It has
been shown earlier that up to 50 % of patients with ele-
vated troponin and unobstructed coronary arteries had
myocarditis as diagnosed by cardiac MRI [31]. In another
recent study [20] where 152 patients with MINCA under-
went cardiac MRI, the findings were normal in two thirds
of the patients, 7 % had signs of myocarditis and about
20 % signs of myocardial necrosis. Amongst patients
with normal MRI, 32 % had typical clinical signs and
symptoms of Takotsubo cardiomyopathy and reversible
wall motion abnormalities. Interestingly, the initial diag-
nosis of AMI was changed in two thirds of the patients
after the MRI examination. These findings suggest that a
significant part of this population actually has other diag-
noses than AMI and more extensive evaluation than just
coronary angiography is needed.
Clinical implications
It is known that the diagnosis of acute myocardial infarc-
tion can have important implications for patient and
family in terms of psychological well-being [32, 33], health
insurance, choice of future profession and professional
licenses (e.g. driving or pilot). There are also implications
for the society related to sick leave, pension-and insurance
claims [34], diagnosis coding, health statistics and health
system reimbursements.
All these personal and societal implications as well as the
extensive secondary prevention commonly prescribed after
a myocardial infarction, imply the need for correct diagno-
sis and suggest the use of advanced imaging modalities
such as MRI, OCT and IVUS in patients presenting as hav-
ing AMI but with no or minimal coronary atherosclerosis.
Study limitations
A limitation of the study is that echocardiography was
not part of the study protocol and it was left to the treat-
ing physician to decide if an echocardiographic examin-
ation was necessary and when to perform it. Though we
finally had access to echocardiography in the majority of
patients, the content of the examinations and the param-
eter analysis was not predefined. Another limitation of
the study is the low inclusion rate which raises thoughts
that we may have had selection bias in the inclusion
phase.
Conclusions
Despite a diagnosis of AMI, based on ESC guidelines cri-
teria, the majority of patients with a completely normal
ICA showed no coronary plaques on CTCA. A few patients
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had only minimal non-obstructive atherosclerosis. Our data
suggest that most patients either had AMI caused by a
mechanism not involving plaque rupture or had other pos-
sible diagnoses that were overlooked. Bearing in mind what
consequences a diagnosis of AMI confers to the patient it is
reasonable to extend the diagnostic evaluation of these pa-
tients to cardiac MRI for excluding myocarditis and/or
intravascular imaging (OCT or IVUS) to provide informa-
tion about some mechanisms of coronary damage.
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